PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM CLEARED FOR PHASE 3 TRIAL BY US FDA, page-26

  1. 1,582 Posts.
    lightbulb Created with Sketch. 631
    Just fantastic news
    Huge roller coaster and such is the journey with biotech but great that our confidence wasn’t misplaced. A 6 month delay in the scheme of things - a blink of an eye in the entire journey from P1 to commercialisation. Now we can reverse that recent trend on the market and look forward to positive news on this and other indications in the months ahead. Enjoy the day!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.